Positive effect of dietary soy in ESRD patients with systemic inflammation--correlation between blood levels of the soy isoflavones and the acute-phase reactants.

Fanti P, Asmis R, Stephenson TJ, Sawaya BP, Franke AA. Positive effect of dietary soy in ESRD patients with systemic inflammation--correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol Dial Transplant. 2006 Aug; 21(8):2239-46.

View in: PubMed

subject areas

Acute-Phase Proteins
Beverages
C-Reactive Protein
Dairy Products
Diabetic Nephropathies
Dietary Proteins
Dietary Supplements
Double-Blind Method
Energy Intake
Female
Food, Formulated
Humans
Inflammation
Insulin-Like Growth Factor I
Interleukin-6
Isoflavones
Kidney Failure, Chronic
Male
Middle Aged
Prealbumin
Serum Albumin
Soy Foods
Tumor Necrosis Factor-alpha

authors with profiles

Adrian Franke, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support